More new shorts were added in Nasdaq stocks in the end of March, but they declined on NYSE names.» Read More
*Men's Wearhouse to acquire Jos. A. Bank Clothiers. Shares of retailers American Eagle and Urban Outfitters fell sharply after disappointing outlooks. They're just taking some money off the table, "said Frank Lesh, futures analyst and broker at FuturePath Trading LLC in Chicago.
*J.C. Penney jumps after Citi upgrade. *Copper prices fall to lowest since July 2010. "When you get a slow data week, markets tend to get a little jittery and slow," said Quincy Krosby, market strategist at Prudential Financial in Newark, New Jersey.
*J.C. Penney jumps after Citi upgrade. *Urban Outfitters tumbles after warning. NEW YORK, March 11- U.S. stocks were little changed on Tuesday as investors found few reasons to push the S&P 500 above its recent record high, as tensions in Ukraine continued.
*J.C. Penney jumps after Citi upgrade. *Myriad Genetics falls after court motion denied. NEW YORK, March 11- U.S. stocks were set for a flat open on Tuesday after a slight decline in the prior session left the S&P 500 within striking distance of its recent record high and amid investor caution as tensions in Ukraine continued.
March 11- Myriad Genetics Inc said a U.S. court denied its motion to temporarily stop rival Ambry Genetics Corp from selling products similar to Myriad's gene-based cancer test, the latest setback for the diagnostics company.
*J.C. Penny jumps after Citi upgrade. *Myriad Genetics falls after court motion denied. NEW YORK, March 11- U.S. stock index futures were little changed on Tuesday after a slight decline in the prior session left the S&P 500 within striking distance of its recent record high and as tensions in Ukraine tempered investor appetite for risk-taking.
March 11- Diagnostics company Myriad Genetics Inc said a U.S. court denied a motion that would have stopped rival Ambry Genetics Corp from selling a similar version of Myriad's cancer test. The company had filed a complaint against Ambry in the U.S. District Court of Utah last July, alleging that Ambry's tests infringed some of its patents.
Some of Monday's midday movers.
Tuesday's midday movers:
Check out which companies are making headlines after the bell Tuesday:
Tuesday’s retail sales should be an important check up on consumers and could show they are picking up their pace of spending.
Biotech and drug companies say the benefits of genome research are on the way, and just as importantly, advances are pushing the technology toward affordability.
The Supreme Court unanimously ruled that human genes cannot be patented, with CNBC's Bertha Coombs; David Resnick, Nixon Peabody LLP; Mitch Epner, Wilk Auslander Counsel; and Rich Lowry, National Review.
A unanimous Supreme Court decision barred patents on naturally occurring DNA, but analysts said the ruling did little harm to biotech companies.
CNBC's Bertha Coombs reports shares of Myriad Genetics are hitting an all-time high after the Supreme Court ruled a naturally occurring human gene cannot be patented, but upheld key DNA patents of Myriad's BRACAnalysis test.
The Supreme Court ruled a naturally occurring human gene cannot be patented, but upheld key DNA patents of Myriad's BRACAnalysis test. CNBC's Bertha Coombs reports.
A check on biotech stocks after the Supreme Court justices say naturally occurring human genes cannot be patented, with CNBC's Seema Mody.
Shares of genetic test maker rose 4 percent, after actress Anjolina Jolie said to undergo double-mastectomy, following testing which showed she carried a gene for breast cancer.
The Supreme Court will hear arguments in a case that calls into question whether DNA can be claimed as intellectual property, and remain off limits without the permission of the patent holder.
Take a look at some of Thursday's midday movers: